[ Price : $8.95]
FDA schedules two November workshops on aspects of next generation sequencing clinical test regulation.[ Price : $8.95]
FDA extends by three months its review of an Alexon Pharmaceuticals BLA for Kanuma (sebelipase alfa), an investigational enzyme re...[ Price : $8.95]
FDA approves an AstraZeneca supplemental NDA for Brilinta (ticagrelor) tablets and a new 60mg dose to be used in patients with a h...[ Price : $8.95]
FDA grants Chugai Pharmaceutical Co. a breakthrough therapy designation for ACE910, an investigational therapy for the prophylacti...[ Price : $8.95]
The U.S. Government Accountability Office agrees to investigate FDAs role in first clearing and then warning 20 years later agains...[ Price : $8.95]
Federal Register final rule: FDA amends the animal drug regulations to reflect application-related actions for new animal drug app...[ Price : $8.95]
Sanofi subsidiary Genzyme agrees to pay $32.5 million to resolve criminal charges that it violated FDA regulations over its allege...[ Price : $8.95]
FDA approves a Wellstat Therapeutics NDA for Xuriden (uridine triacetate), the first approved treatment for patients with heredita...